Cumulative risks of events. Cumulative risk of thrombosis (A), myelofibrosis (B), acute myeloid leukemia (C), and survival (D) in 106 patients with polycythemia vera carrying JAK2 exon 12 mutations. For each graph, the number of patients at risk is reported.